BeStock  
股票 › 生物科技 › APMD

艾普尼美德 APMD

美股市值排名 #3548生物科技
$15.10 +$0.94 (+6.64%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.10 0.00%
开盘$14.26
昨收$14.16
当日区间$14.11 – $15.41
成交量225.4K
市值$628.62M
市盈率(TTM)3.9
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$12.08M-29.4% YoY
营业利润-$11.70M-97.2% YoY
净利润$125.94M+281.3% YoY
摊薄每股收益$3.16+230.9% YoY
自由现金流-$18.45M-6.2% YoY
经营现金流-$18.11M

营收,近4个季度

$3.1MMar '25$17.1MJun '25$84.8MMar '26$12.1MJun '26

净利润,近4个季度

$-28.6MMar '25$-69.5MJun '25$70.4MMar '26$125.9MJun '26

各季度摊薄每股收益

-1.00Mar '25-2.42Jun '252.12Mar '263.16Jun '26

各季度自由现金流

$-28.5MMar '25$-17.4MJun '25$-19.8MMar '26$-18.4MJun '26

盈利能力与资产负债表

毛利率93.9%
营业利润率30.9%
净利率252.6%
资产收益率148.8%
流动比率5.19
负债/资产比率190.1%
现金及投资$172.80M
总负债$80.08M
净现金(净负债)$92.72M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2024 ANNUAL
-现金及现金等价物 $172.80M $328.88M $41.89M $68.35M
现金及现金等价物与短期投资 $172.80M $328.88M $41.89M $68.35M
流动资产合计 $184.77M $332.00M $45.06M $73.25M
总资产 $195.46M $342.63M $72.87M $109.22M
-普通股 $1,000.00 $1,000.00 $1,000.00 $1,000.00
股本 $1,000.00 $1,000.00 $1,000.00 $1,000.00
股东权益 -$176.18M $257.59M -$372.78M -$248.62M
股东权益合计 -$176.18M $257.59M -$372.78M -$248.62M
其他非流动负债 $10.04M – $57.12M $64.36M
可转换优先证券 $245.94M $0.00 $221.15M $204.89M
一年以上递延负债 $0.00 $0.00 $15.24M $45.36M
-长期融资租赁负债 $485,000.00 $555,000.00 $623,000.00 $873,000.00
-长期债务 $79.60M $46.10M $40.65M –
长期债务及融资租赁负债 $80.08M $46.66M $41.27M $873,000.00
非流动负债合计 $336.06M $46.66M $334.78M $315.48M
其他流动负债 $179,000.00 – $86,000.00 $152,000.00
一年内递延负债 $19.53M $30.40M $97.81M $25.00M
-一年内到期融资租赁负债 $265,000.00 $257,000.00 $250,000.00 $222,000.00
短期债务及融资租赁负债 $265,000.00 $257,000.00 $250,000.00 $222,000.00
流动负债合计 $35.58M $38.39M $110.88M $42.36M
资本公积 $27.51M $444.56M $24.56M $20.54M
留存收益 -$203.69M -$186.97M -$397.34M -$269.15M
一年内应计费用 $4.91M $4.72M $4.39M $7.40M
-应付账款 $6.60M $3.01M $1.79M $3.59M
应付款 $6.60M $3.01M $1.79M $3.59M
非流动资产合计 $10.68M $10.64M $27.82M $35.98M
固定资产净值 $10.66M $10.61M $901,000.00 $1.16M
其他非流动资产 $24,000.00 $24,000.00 $26.92M $34.82M
其他流动资产 $5.09M $346,000.00 $665,000.00 $349,000.00
一年内递延资产 $4.78M – – –
-累计折旧 -$64,000.00 – -$51,000.00 -$24,000.00
-应收账款 $690,000.00 $876,000.00 $959,000.00 $1.12M
应收款 $690,000.00 $876,000.00 $959,000.00 $1.12M
负债合计 $371.64M $85.04M $445.66M $357.84M
-固定资产原值 $10.72M $10.61M $952,000.00 $1.18M
预付资产 $1.41M $1.89M $1.54M $3.43M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
持续经营筹资活动现金流净额 $44.37M $24.81M $51.37M $16.29M $0.00
筹资活动现金流 $44.37M $24.81M $51.37M $16.29M $0.00
-其他营运资金变动 -$10.87M -$82.65M -$19.54M -$3.15M -$1.82M
-其他流动负债变动 -$57.18M -$61,000.00 -$7.46M -$7.29M -$53,000.00
-应付账款及应计费用变动 $2.46M -$2.49M -$4.33M -$2.59M -$1.87M
优先股发行净额 $48.19M $25.00M $16.50M $16.50M $0.00
股票期权行使所得 $812,000.00 $16,000.00 $115,000.00 $36,000.00 $0.00
自由现金流 -$18.45M -$19.81M -$77.83M -$17.37M -$28.45M
期初现金余额 $46.89M $41.89M $68.35M $39.90M $68.35M
期末现金余额 $172.80M $46.89M $41.89M $38.82M $39.90M
其他筹资费用净额 -$2.85M -$208,000.00 -$243,000.00 – –
-应收款变动 $186,000.00 $83,000.00 $156,000.00 $7,000.00 $153,000.00
营运资金变动 -$65.75M -$89.07M -$29.59M -$12.67M -$2.64M
其他非现金项目 $2.91M $61,000.00 $230,000.00 $57,000.00 $55,000.00
折旧、折耗与摊销 $7,000.00 $6,000.00 $27,000.00 $6,000.00 $7,000.00
持续经营净利润 $126.11M $70.37M -$58.05M -$5.63M -$26.68M
持续经营经营活动现金流净额 -$18.11M -$19.81M -$77.83M -$17.37M -$28.45M
-预付资产变动 -$342,000.00 -$3.95M $1.58M $347,000.00 $950,000.00
经营活动现金流 -$18.11M -$19.81M -$77.83M -$17.37M -$28.45M
现金净变动 $125.92M $5.00M -$26.46M -$1.08M -$28.45M
投资活动现金流净额 – – $0.00 – –
持续经营投资活动现金流净额 – – $0.00 – –
固定资产购置及出售净额 – – $0.00 – –
投资购置及出售净额 – – $0.00 – –
债务发行及偿还净额 – – $35.00M – –

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
报告营业总收入 $12.08M $38.47M $38.47M $17.11M $3.13M
营业总收入 $12.08M $84.81M $38.47M $17.11M $3.13M
营业成本 $1.21M $2.16M $6.69M $1.72M $1.32M
毛利润 $10.87M $82.65M $31.77M $15.39M $1.81M
营业费用 $22.57M $14.61M $85.59M $21.32M $28.93M
净利润 $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
销售及管理费用 $12.67M $6.51M $23.49M $5.35M $5.47M
-销售及营销费用 $4.83M – – $859,000.00 $730,000.00
-管理费用 $7.85M $6.51M $23.49M $4.49M $4.74M
归属母公司净利润 $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
归属普通股股东净利润 $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
基本每股收益 $3.16 $2.45 -$0.03 -$2.42 -$1.00
摊薄每股收益 $3.16 $2.12 -$0.03 -$2.42 -$1.00
终止经营净利润 -$178,000.00 – – -$63.85M -$1.97M
持续经营利润 $126.11M $70.37M -$932,000.00 -$5.63M -$26.68M
研发费用 $9.90M $8.10M $62.10M $15.97M $23.46M
非经营性利息净收入(支出) $970,000.00 $218,000.00 $1.41M $309,000.00 $431,000.00
非经营性利息收入 $970,000.00 $218,000.00 $1.41M $309,000.00 $431,000.00
其他收入(支出) $136.85M $2.11M $51.47M – –
特殊收益(费用) $85.38M – – $0.00 –
-业务出售收益 $85.38M – – $0.00 –
其他非经营性收入(支出) $51.47M $2.11M $51.47M – –
税前利润 $126.11M $70.37M -$932,000.00 -$5.63M -$26.68M
税费 $0.00 $0.00 $0.00 $0.00 $0.00
营业利润 -$11.70M $68.04M -$53.82M -$5.94M -$27.11M

讨论区

暂无评论——快来第一个聊聊 APMD。

登录后参与讨论。

Scroll to Top